Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trial
GV1001联合吉西他滨/卡培他滨治疗既往未接受治疗且血清嗜酸性粒细胞趋化因子（eotaxin）水平高的晚期胰腺导管腺癌患者的疗效（KG4/2015）：一项开放标签、随机、3期试验
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-023-02474-w
Jo, Jung Hyun; Kim, Yong-Tae; Choi, Ho Soon; Kim, Ho Gak; Lee, Hong Sik; Choi, Young Woo; Kim, Dong Uk; Lee, Kwang Hyuck; Kim, Eui Joo; Han, Joung-Ho; Lee, Seung Ok; Park, Chang-Hwan; Choi, Eun Kwang; Kim, Jae Woo; Cho, Jae Yong; Lee, Woo Jin; Moon, Hyungsik Roger; Park, Mi-Suk; Kim, Sangjae; Song, Si Young
